Canon

Canon Medical Systems established the Japanese joint venture — called ACTmed — with Taiwanese molecular diagnostics firm ACT Genomics.

The exclusive deal includes sales and marketing of a rapid thermal cycler as well as consumable microplates and pipette tips. 

The deal covers Canon BioMedical's Novallele line of genotyping and copy number assays in Austria, Germany, and Switzerland.

Sanbio, a Netherlands-based distributor that serves the Belgium, the Netherlands, and Luxembourg, will distribute Canon's Novallele assays and controls.

The companies have been working together since early 2015 on a diagnostic for the early detection of Lyme disease.

The investment will fund the research and development of new diagnostic testing products, including rapid genetic testing.

The partners will work together to build a rapid diagnostic test panel for Lyme Disease using T2's magnetic resonance detection technology.